Table 4.
All PAD participants (n=34)a | ABI < 0.60 (n=l2) | ABI 0.60–0.90 (n=2l) | |
---|---|---|---|
Relative COX activity | |||
Pearson correlation coefficient with mitochondrial DNA copy number | 0.385 | 0.478 | 0.3l6 |
p-value | p=0.033 | p=0.ll6 | p=0.202 |
Relative citrate synthase activity | |||
Pearson correlation coefficient with mitochondrial DNA copy number | 0.038 | −0.25l | 0.479 |
p-value | p=0.835 | p=0.432 | p=0.038 |
Log-transformed PGC-1α | |||
Pearson correlation coefficient with mitochondrial DNA copy number | 0.253 | 0.03l | 0.453 |
p-value | p=0.l69 | p=0.924 | p=0.059 |
Maximum relative brachial artery FMD 60/90 (%) | |||
Pearson correlation coefficient with mitochondrial DNA copy number | 0.255 | −0.043 | 0.465 |
p-value | p=0.l66 | p=0.90l | p=0.039 |
ABI, ankle–brachial index; FMD, flow-mediated dilation; MtDNA, mitochondrial DNA; PAD, peripheral artery disease.
One participant with documented PAD and a history of revascularization had an ABI > 0.90.